PSYCHIATRIC EPIDEMIOLOGY AND BURDEN OF DISEASE

Recent Peer-Reviewed Publications

2016

Baxter, A. J., Charlson, F. J., Cheng, H. G., Shidhaye, R., Ferrari, A. J., & Whiteford, H. A. (2016). Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis. The Lancet Psychiatry, 3(9), 832-841. doi: 10.1016/S2215-0366(16)30139-0 EPub: 12 Aug 2016.

Charlson, F. J., Baxter, A. J., Cheng, H. G., Shidhaye, R., & Whiteford, H. A. (2016). The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. The Lancet, 388(10042), 376-389. doi: 10.1016/S0140-6736(16)30590-6 EPub: 18 May 2016.

Charlson, F. J., Flaxman, A., Ferrari, A. J., Vos, T., Steel, Z., & Whiteford, H. A. (2016). Post-traumatic stress disorder and major depression in conflict-affected populations: an epidemiological model and predictor analysis. Global Mental Health, 3(e4), 1-11. doi: 10.1017/gmh.2015.26 EPub: 10 Feb 2016.

Charlson, F. J., Lee, Y. Y., Diminic, S., & Whiteford, H. (2016). Applications of the epidemiological modelling outputs for targeted mental health planning in conflict-affected populations: the Syria case-study. Global Mental Health, 3(e8), 1-13. doi: 10.1017/gmh.2016.4 EPub: 7 Mar 2016.

Cheng, H. G., Shidhaye, R., Charlson, F., Deng, F., Lyngdoh, T., Chen, S., . . . Whiteford, H. (2016). Social correlates of mental, neurological, and substance use disorders in China and India: a review. The Lancet Psychiatry, 3(9), 882-899. doi: 10.1016/S2215-0366(16)30166-3 EPub: 12 Aug 2016.

Degenhardt, L., Charlson, F., Stanaway, J., Larney, S., Alexander, L. T., Hickman, M., . . . Vos, T. (2016). Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. The Lancet Infectious Diseases, 16(12), 1385-1398. doi: 10.1016/S1473-3099(16)30325-5 EPub: 20 Sep 2016.

Erskine, H. E., Baxter, A. J., Patton, G., Moffitt, T. E., Patel, V., Whiteford, H. A., & Scott, J. G. (2016). The global coverage of prevalence data for mental disorders in children and adolescents. Epidemiol Psychiatr Sci, doi: 10.1017/S204579601500115 EPub: 20 Jan 2016.

Erskine, H. E., Norman, R. E., Ferrari, A. J., Chan, G. C. K., Copeland, W. E., Whiteford, H. A., & Scott, J. G. (2016). Long-Term Outcomes of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder: A Systematic Review and Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 55(10), 841-850. doi: 10.1016/j.jaac.2016.06.016 EPub: 3 Aug 2016.

Erskine, H. E., Whiteford, H. A., & Pike, K. M. (2016). The global burden of eating disorders. Curr Opin Psychiatry, 29(6), 346-353. doi: 10.1097/yco.0000000000000276 EPub: 16 Aug 2016.

Ferrari, A. J., Stockings, E., Khoo, J. P., Erskine, H. E., Degenhardt, L., Vos, T., & Whiteford, H. A. (2016). The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. Bipolar Disord, 18(5), 440-450. doi: 10.1111/bdi.12423 EPub: 27 Aug 2016.

Global Burden of Disease Pediatrics Collaboration. (2016). Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: Findings from the global burden of disease 2013 study. JAMA Pediatrics, 170(3), 267-287. doi: 10.1001/jamapediatrics.2015.4276 EPub: 25 Jan 2016. [QCMHR authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Whiteford, H. A.].

Lee, Y. Y., Barendregt, J. J., Stockings, E. A., Ferrari, A. J., Whiteford, H. A., Patton, G. A., & Mihalopoulos, C. (2016). The population cost-effectiveness of delivering universal and indicated school-based interventions to prevent the onset of major depression among youth in Australia. Epidemiol Psychiatr Sci, 1-20. doi: 10.1017/s2045796016000469 EPub: 11 Aug 2016.

Leske, S., Harris, M. G., Charlson, F. J., Ferrari, A. J., Baxter, A. J., Logan, J. M., . . . Whiteford, H. (2016). Systematic review of interventions for Indigenous adults with mental and substance use disorders in Australia, Canada, New Zealand and the United States. Australian and New Zealand Journal of Psychiatry, 50(11), 1040-1054. doi: 10.1177/0004867416662150 EPub: 11 Aug 2016.

McGrath, J. J., Charlson, F., & Whiteford, H. A. (2016). Challenges and Options for Estimating the Prevalence of Schizophrenia, Psychotic Disorders, and Bipolar Disorders in Population Surveys. Standing Committee On Integrating New Behavioral Health Measures Into The Substance Abuse And Mental Health Services Administration’s Data Collection Programs. Retrieved from http://sites.nationalacademies.org/cs/groups/dbassesite/documents/webpage/dbasse_173004.pdf EPub: 17 Jun 2016.

Patel, V., Chisholm, D., Parikh, R., Charlson, F., Degenhardt, L., Dua, T., Ferrari, A., Hyman, S., Laxminarayan, R., Levin, C., Lund, C., Medina-Mora, M. E., Petersen, I., Scott, J., Shidhaye, R., Vijayakumar, L., Thornicroft, G., & Whiteford, H. (2016). Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. The Lancet, 387(10028), 1672-1685. doi: 10.1016/S0140-6736(15)00390-6 EPub: 8 Oct 2015.

Stockings, E. A., Degenhardt, L., Dobbins, T., Lee, Y. Y., Erskine, H. E., Whiteford, H. A., & Patton, G. (2016). Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychological Medicine, 46(1), 11-26. doi: 10.1017/S0033291715001725 EPub: 28 Aug 2015.

Waller, M., Charlson, F. J., Ireland, R. E. E., Whiteford, H. A., & Dobson, A. J. (2015). Time-course of PTSD symptoms in the Australian Defence Force: a retrospective cohort study. Epidemiology and Psychiatric Sciences, 25(4), 393-402. doi: 10.1017/S2045796015000517 EPub: 16 Jun 2015

Whiteford, H., Ferrari, A., & Degenhardt, L. (2016). Global burden of disease studies: Implications for mental and substance use disorders. Health Affairs, 35(6), 1114-1120. doi: 10.1377/hlthaff.2016.0082

GBD 2015 Capstone Papers

Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., . . . Murray, C. J. L. (2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1659-1724. doi: 10.1016/S0140-6736(16)31679-8 [QCMHR/PEABOD affiliate authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Leung, J., McGrath, J. J., Santomauro, D. F., Scott, J. G., Whiteford, H. A.].

Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., . . . Murray, C. J. L. (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1603-1658. doi: 10.1016/S0140-6736(16)31460-X [QCMHR/PEABOD affiliate authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Leung, J., McGrath, J. J., Whiteford, H. A.].

Lim, S. S., Allen, K., Bhutta, Z. A., Dandona, L., Forouzanfar, M. H., Fullman, N., . . . Murray, C. J. L. (2016). Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1813-1850. doi: 10.1016/S0140-6736(16)31467-2 EPub: 21 Sep 2016. [QCMHR/PEABOD affiliate authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Leung, J., McGrath, J. J., Santomauro, D. F., Whiteford, H. A.].

Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., . . . Murray, C. J. L. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1545-1602. doi: 10.1016/S0140-6736(16)31678-6 [QCMHR/PEABOD affiliate authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Leung, J., McGrath, J. J., Scott, J. G., Whiteford, H. A.].

Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., . . . Murray, C. J. L. (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1459-1544. doi: 10.1016/S0140-6736(16)31012-1 [QCMHR/PEABOD affiliate authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Leung, J., McGrath, J. J., Saha S., Scott, J. G., Whiteford, H. A.].

2015

Baxter, A. J., Brugha, T. S., Erskine, H. E., Scheurer, R. W., Vos, T., & Scott, J. G. (2015). The epidemiology and global burden of autism spectrum disorders. Psychological Medicine, 45(3), 601-613. doi: http://dx.doi.org/10.1017/S003329171400172X.

Charlson, F. J., Baxter, A. J., Dua, T., Degenhardt, L., Whiteford, H. A., & Vos, T. (2015). Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010. Epidemiology and Psychiatric Sciences, 24(2), 121-140. doi: 10.1017/S2045796014000687. EPub: 15 Dec 2014.

Charlson, F. J., Diminic, S., & Whiteford, H. A. (2015). The Rising Tide of Mental Disorders in the Pacific Region: Forecasts of Disease Burden and Service Requirements from 2010 to 2050. Asia and the Pacific Policy Studies, 2(2), 280-292. doi: 10.1002/app5.93.

Charlson, F. J. & Erskine, H. E. (2015). Burden of mental and substance use disorders in Indigenous Australians and Oceania. Australasian Psychiatry, 23(6 suppl), 13-16. doi: 10.1177/1039856215608295

Charlson, F., Redman-MacLaren, M., & Hunter, E. (2015). Evaluation of a Leadership in Mental Health course for Pacific Island Nation delegates. Australasian Psychiatry, 23(6 suppl), 38-41. doi: 10.1177/103985621561297

Erskine, H. E., Moffitt, T. E., Copeland, W. E., Costello, E. J., Ferrari, A J., Patton, G., Degenhardt, L., Vos, T., Whiteford H. A., & Scott, J. G. (2015). A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. Psychological Medicine, 45(7), 1551-1563. doi: 10.1017/S0033291714002888.

Lara, E., Garin, N., Ferrari, A. J., Tyrovolas, S., Olaya, B., Sànchez-Riera, L., Whiteford, H. A., &  Haro, J. M. (2014). The Spanish burden of disease 2010: Neurological, mental and substance use disorders. Revista de Psiquiatría y Salud Mental, 8(4), 207-217. doi: 10.1016/j.rpsm.2014.09.001. EPub: 27 Nov 2014.

Moore, S. E., Scott, J. G., Ferrari, A. J., Mills, R., Dunne, M. P., Erskine, H. E., Devries, K. M., Degenhardt, L., Vos, T., Whiteford, H. A., McCarthy, M., & Norman, R. E. (2015). Burden attributable to child maltreatment in Australia. Child Abuse and Neglect, 48, 208-220. doi: 10.1016/j.chiabu.2015.05.006. EPub: 5 Jun 2015Sawyer, M. G., Erskine, H. E., Sawyer, A. C., Morrissey, M., & Lynch, J. W. (2015). Childhood mental disorders: A forgotten problem? Australian and New Zealand Journal of Psychiatry, 49(9), 774-775. doi: 10.1177/0004867415592958. EPub: 30 Jun 2015.

Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015) The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010. PLoS ONE 10(2): e0116820. doi: 10.1371/journal.pone.0116820

GBD 2013 Capstone Papers

Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., . . . Murray, C. J. (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 386(10010), 2287-2323. doi: http://dx.doi.org/10.1016/S0140-6736(15)00128-2. EPub: 11 Sep 2015. [QCMHR authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., Saha, S., Scott, J. G., Whiteford, H. A.].

GBD 2013 Mortality and Causes of Death Collaborators. (2015). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 385, 117-171. doi: 10.1016/S0140-6736(14)61682-2. EPub: 18 Dec 2014. [QCMHR authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., McGrath, J. J., Saha, S., Scott, J. G., Whiteford, H. A.].

Murray, C. J. L., Barber, R. M., Foreman, K. J., Ozgoren, A. A., Abd-Allah, F., Abera, S. F., . . . Vos, T. (2015). Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet, 386(10009), 2145-2191. doi: 10.1016/S0140-6736(15)61340-X EPub: 26 Aug 2015. [QCMHR authors: Charlson, F. J., Degenhardt, L., Erskine, H.E., Ferrari, A. J., McGrath, J. J., Saha, S., Scott, J. G., Whiteford, H. A]

Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., . . . Murray, C. J. L. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 386(9995), 743-800. doi: 10.1016/S0140-6736(15)60692-4 EPub: 7 Jun 2015 [QCMHR authors: Charlson, F. J., Degenhardt, L., Erskine, H. E., Ferrari, A. J., McGrath, J. J., Saha, S., Scott, J. G., Whiteford, H. A.].

2014

Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Degenhardt, L., & Whiteford, H. A. (2014). The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD 2010. Epidemiology and Psychiatric Sciences, 23 (3), 239-249. doi: 10.1017.S2045796014000237.

Baxter, A. J., Scott, K. M., Ferrari, A. J., Norman, R. E., Vos, T., & Whiteford, H. A. (2014). Challenging the myth of an ‘epidemic’ of common mental disorders: Trends in the global prevalence of anxiety and depression between 1990 and 2010. Depression and Anxiety, 31(6), 506-516. doi: 10.1002/da.22230.

Baxter, A. J., Vos, T., Scott, K. M., Ferrari, A. J., & Whiteford, H. A. (2014). The global burden of anxiety disorders in 2010. Psychological Medicine, 44(11),2363-2374. doi: 10.1017/S0033291713003243.

Baxter, A. J., Vos, T., Scott, K. M., Norman, R. E., Flaxman, A. D., Blore, J., & Whiteford, H. A. (2014). The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010. International Journal of Methods in Psychiatric Research, 23(4), 422-438. doi: 10.1002/mpr.1444.

Charlson, F. J., Diminic, S., Lund, C., Degenhardt, L., & Whiteford, H. A. (2014). Mental and substance use disorders in sub-Saharan Africa: Predictions of epidemiological changes and mental health workforce requirements for the next 40 years. PLoS One, 9(10), e110208. doi: 10.1371/journal.pone,0110208.

Degenhardt, L., Baxter, A. J., Lee, Y., Hall, W., Sara, G. E., Johns, N., Flaxman, A., Whiteford, H. A., & Vos, T. (2014). The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. Drug and Alcohol Dependence, 137(1 April 2014), 36-47. doi: 10.1016/j.drugalcdep.2013.12.025.

Degenhardt, L., Charlson, F., Mathers, B., Hall, W. D., Flaxman, A. D., Johns, N., & Vos, T. (2014). The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction, 109(8), 1320-1333. doi: 10.1111/add.12551.

Degenhardt, L., Whiteford, H., & Hall, W. D. (2014). The Global Burden of Disease projects: What have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug and Alcohol Review, 33, 4-12.

Erskine, H. E., Ferrari, A. J., Polanczyk, G. V., Moffitt, T. E., Murray, C. J. L., Vos, T., . . . Scott, J. G. (2014). The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. Journal of Child Psychology and Psychiatry, 55(4), 328-336. doi: 10.1111/jcpp.12186.

Ferrari, A. J., Norman, R. E., Freedman, G., Baxter, A. J., Pirkis, J. E., Harris, M. G., Page, A., Carnahan, E., Degenhardt, L., & Whiteford, H. A. (2014). The burden attributable to mental and substance use disorders as risk factors for suicide: Findings from the Global Burden of Disease Study 2010. PLoS One, 9(4), e91936. doi: 10.1371/journal.pone.0091936.

Saha, S., Whiteford, H., & McGrath, J. (2014). Modelling the incidence and mortality of psychotic disorders: Data from the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 48(4), 352-359. doi: 10.1177/0004867413513341.

Sara, G. E., Burgess, P. M., Malhi, G. S., Whiteford, H. A., & Hall, W. C. (2014). The impact of cannabis and stimulant disorders on diagnostic stability in psychosis. Journal of Clinical Psychiatry, 75(4), 349-356.

Sara, G., Burgess, P. M., Malhi, G., Whiteford, H. A., & Hall, W. (2014). Stimulant use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Australian and New Zealand Journal of Psychiatry. 48(11), 1036-1047. doi: 10.1177/0004867414533838.

2013

Baxter, A.J., Patton, G., Scott, K.,M., Degenhardt, L, & Whiteford, H.A. (2013). Global Epidemiology of Mental Disorders: What Are We Missing? PLoS ONE, 8(6):e65514.

Baxter, A. J., Scott, K. M., Vos, T., & Whiteford, H. A. (2013). Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med, 43(5), 897-910. Epub 2012 Jul 10.

Charlson, F. J., Ferrari, A. J., Flaxman, A. D., & Whiteford, H. A. The epidemiological modelling of dysthymia: Application for the Global Burden of Disease Study 2010. Journal of Affective Disorders, 151(1), 111-120. doi: http://dx.doi.org/10.1016/j.jad.2013.05.060.

Charlson, F. J., Moran, A. E., Freedman, G., Norman, R. E., Stapelberg, N. J. C., Baxter, A. J., Vos T., & Whiteford, H. A. (2013). The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Medicine, 11(1): 250.

Degenhardt, L., Ferrari, A. J., Calabria, B., Hall, W. D., Norman, R. E., McGrath, J., . . . Vos, T. (2013). The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study. PLoS One, 8(10), e76635.

Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., . . . Vos, T. (2013). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. The Lancet, 382(9904), 1564-1574. doi:10.1016/S0140-6736(13)61530-5.

Erskine, H. E., Ferrari, A. J., Nelson, P., Polanczyk, G. V., Flaxman, A. D., Vos, T., Whiteford, H. A., & Scott, J. G. (2013). Research Review: Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. Journal of Child Psychology and Psychiatry, 54(12), 1263-1274.

Ferrari, A. J., Charlson, F. J., Norman, R. E., Flaxman, A. D., Patten, S. B., Vos, T., & Whiteford, H. A. (2013). The epidemiological modelling of major depressive disorder : Application for the Global Burden of Disease Study 2010. PLoS One, 8(7), 1-14.

Ferrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013). Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med, 43(3), 471-481. Epub 2012 Jul 25.

Ferrari, A.J., Charlson, F. J., Norman, R. E., Patten, S.B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013). Burden of depressive disorders by country, sex, age and year: Findings from the Global Burden of Disease Study 2010. PloS Medicine, 10(11), e1001547.

GBD 2010 Country Collaboration. (2013). GBD 2010 country results: a global public good. The Lancet, 381(9871), 965-970.

Whiteford, H. A., & Baxter, A. J. (2013). The Global Burden of Disease 2010 Study: what does it tell us about mental disorders in Latin America? Revista Brasileira de Psiquiatria, 35(2), 1-2.

Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., . . . Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The Lancet, 382(9904), 1575-1586. doi:10.1016/S0140-6736(13)61611-6.

Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., & Degenhardt, L. (2013). How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010? Current Opinion in Psychiatry, 26(4), 376-383.

2012

Charlson, F., Siskind, D., Doi, S. A. R., McCallum, E., Broome, A., & Lie, D. C. (2012). ECT efficacy and treatment course: A systematic review and meta-analysis of twice vs thrice weekly schedules. Journal of Affective Disorders, 138, 1-8.

Charlson, F. J., Steel, Z., Degenhardt, L., Chey, T., Silove, D., Marnane, C., & Whiteford, H. A. (2012). Predicting the Impact of the 2011 Conflict in Libya on Population Mental Health: PTSD and Depression Prevalence and Mental Health Service Requirements. PLoS One, 7(7):e40593. Epub 2012 Jul 13.

Degenhardt, L. & Hall, W. (2012). The extent of illicit drug use, dependence, and their contribution to global burden of disease. The Lancet, 379(9810), 55-70.

Ferrari, A. J., Saha, S., McGrath, J. J., Norman, R., Baxter, A. J., Vos, T., et al. (2012). Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study. Popul Health Metr, 10(1), 16. doi:10.1186/1478-7954-10-16.

Siskind, D., Charlson, F., Saraf, S., Scheurer, R., & Lie, D. C. (2012). Twice versus thrice weekly ECT in a clinical population: An evaluation of patient outcomes. Psychiatry Research, 199(3), 208-211.

GBD 2010 Capstone Papers

Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2095-2128.

Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., et al. (2012). Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2129-2143.

Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2163-2196.

Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2197-2223.

Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2224-2260.

Letters to the Editor, Commentaries and Responses

Baxter AJ, Harris M, Khatib Y & Bhui K (2014) Review into interventions to reduce premature mortality due to chronic disease in people with severe mental disorders. Policy Development Paper. NHS, England.

Degenhardt, L., Hall, W., & Whiteford, H. A. (2014). Illicit drug dependence across the globe: Results from the Global Burden of Disease 2010 Study. Psychiatric Times. Epub: 13 Feb 2014. Available from http://www.psychiatrictimes.com/special-reports/illicit-drug-dependence-across-globe

Ferrari, A. J. (2016). The global distribution of mental and substance use disorders: research gains and challenges. Epidemiol Psychiatr Sci, 25(03), 230-232. doi: 10.1017/S204579601500102X EPub: 21 Dec 2015.

Whiteford, H. A., Baxter, A.J., Bhui, K., & Brugha, T. S. (2013). Rapid response to “The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers”. BMJ, Published online 19 June 2013; http://www.bmj.com/content/346/bmj.f2539/rr/650543.

Whiteford, H. A., Degenhardt, L., Murray, C. J. L., Vos, T., & Lopez, A. D. (2014). Commentary: Improving the mental health and substance use estimates in the Global Burden of Disease study: strengthening the evidence base for public policy. International Journal of Epidemiology, 43(2), 296-301.. doi: 10.1093/ije/dyu052.

Whiteford, H. A., Ferrari, A. J., & Vos, T. (2016). Challenges to estimating the true global burden of mental disorders. The Lancet Psychiatry, 3(5), 402-403. doi: 10.1016/S2215-0366(16)30026-8

Book chapters

Baxter, A. J., Blore, J., Flaxman, A. D., Peterson, H. M., Vos, T. & Whiteford, H. Expert priors in compartmental models. In: Flaxman, A. D., Vos, T., & Murray, C. J. L. eds. An Integrative Metaregression Framework For Descriptive Epidemiology. Seattle and London: University of Washington Press; 2015:165-170.

Charlson, F., Baxter, A., Dua, T., Degenhardt, L., Whiteford, H., & Vos, T. (2015). Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010. In V. Patel, Chisholm, D., Dua, T., Laxminarayan, R. & Medina-Mora, M. E. (Ed.), Mental, Neurological, and Substance Use Disorders. Disease Control Priorities. (3rd ed., Vol. 4). Washington, DC: World Bank.

Ferrari, A., Flaxman, A. D., Vos, T. & Whiteford, H. Cross-walking with fixed effects. In: Flaxman, A. D., Vos, T., & Murray, C. J. L. eds. An Integrative Metaregression Framework For Descriptive Epidemiology. Seattle and London: University of Washington Press; 2015:141-144.

Lee, Y. Y., Vos, T., Flaxman, A. D., Blore, J., & Degenhardt, L. Knot selection in spline models. In: Flaxman, A. D., Vos, T., & Murray, C. J. L. eds. An Integrative Metaregression Framework For Descriptive Epidemiology. Seattle and London: University of Washington Press; 2015:109-116.

Mihalopoulus, C., Baxter, A. J., Whiteford, H. A., & Vos, T. (2014). The Cost-Effectiveness of Treatments for Anxiety Disorders. In: Emmelkamp, P., Ehring, T., eds. The Wiley Handbook of Anxiety Disorders: Theory, Research, & Practice. West Sussex: Wiley-Blackwell; 2014.

Patel, V., Chisholm, D., Parikh, R., Charlson, F., Degenhardt, L., Dua, T., Ferrari, A., Hyman, S., Laxminarayan, R., Levin, C., Lund, C., Medina-Mora, M. E., Petersen, I., Scott, J., Shidhaye, R., Vijayakumar, L., Thornicroft, G., & Whiteford, H. (2015). Global Priorities for Addressing the Burden of Mental, Neurological, and Substance Use Disorders. In V. Patel, Chisholm, D., Dua, T., Laxminarayan, R. & Medina-Mora, M. E. (Ed.), Mental, Neurological, and Substance Use Disorders. Disease Control Priorities. (3rd ed., Vol. 4). Washington, DC: World Bank.

Peterson, H. M., Lee, Y. Y., Vos, T., & Flaxman, A. D., Unclear age pattern, requiring expert priors. In: Flaxman, A. D., Vos, T., & Murray, C. J. L. eds. An Integrative Metaregression Framework For Descriptive Epidemiology. Seattle and London: University of Washington Press; 2015:117-124.

Scott, J., Rahman, A., Mihalopoulos, C., Erskine, H., & Roberts, J. (2015). Childhood Mental and Developmental Disorders. In V. Patel, Chisholm, D., Dua, T., Laxminarayan, R. & Medina-Mora, M. E. (Ed.), Mental, Neurological, and Substance Use Disorders. Disease Control Priorities. (3rd ed., Vol. 4). Washington, DC: World Bank.

Whiteford, H.A., & Ferrari, A.J. (2013). The burden of mental disorders in the Global Burden of Disease Study 2010 and the World Mental Health Survey: Similarities, differences and implications for mental health research. In: Alonso J, Chatterji S, Yanling H, eds. The burden of mental disorders in the WHO World Mental Health Surveys: WMH surveys series Volume IV. Cambridge: Cambridge University Press; 221-229.

Whiteford, H., Ferrari, A., Degenhardt, L., Feigin, V., & Vos, T. (2015). Global Burden of Mental, Neurological, and Substance Use Disorders: An Analysis from the Global Burden of Disease Study, 2010. In V. Patel, Chisholm, D., Dua, T., Laxminarayan, R. & Medina-Mora, M. E. (Ed.), Mental, Neurological, and Substance Use Disorders. Disease Control Priorities. (3rd ed., Vol. 4). Washington, DC: World Bank.

Conferences

Erskine, H. (27th October, 2016). The global epidemiology and burden of anorexia nervosa and bulimia nervosa: Findings from the Global Burden of Disease Study 2015 Presented at the XXIInd Annual Meeting of the Eating Disorders Research Society, New York, USA.

Whiteford, H. (27th October, 2016). The global burden of mental and substance use disorders in the Global Burden of Disease Study 2015: Background, key findings, and implications. Presented at the XXIInd Annual Meeting of the Eating Disorders Research Society, New York, USA.

Erskine, H. (23rd July, 2016). The global epidemiology, burden, and outcomes and ADHD and conduct disorder. Presented at the Queensland Faculty of Child and Adolescent Psychiatry Annual Continuing Professional Development Weekend, Gold Coast, Australia.

Leung, J. (4th December, 2015). Investigating prevalence and treatment gaps for depressive disorders in 2013: Where are we now? Presented at the Society for Mental Health Research (SMHR) Conference, Brisbane, Australia.

Charlson, F. J. (4th December, 2015). Applications of epidemiological and burden of disease estimates for targeted mental health planning. Presented at the Society for Mental Health Research (SMHR) Conference, Brisbane, Australia.

Erskine, H. E. (4th December, 2015). A known unknown: The global coverage of prevalence data for mental disorders in children and adolescents. Presented at the Society for Mental Health Research (SMHR) Conference, Brisbane, Australia.

Ferrari, A. J. (4th December, 2015). Global burden of disease study 2013: An overview of methods, limitations and applications of data to estimate the burden of mental and substance use disorders. Presented at the Society for Mental Health Research (SMHR) Conference, Brisbane, Australia.

Degenhardt, L. (4th December, 2015). Global burden of substance use disorders: An overview of findings form GBD 2013. Presented at the Society for Mental Health Research (SMHR) Conference, Brisbane, Australia.

Whiteford, H. A. (4th December, 2015). Global burden of mental and substance use disorders: An overview of findings form GBD 2013. Presented at the Society for Mental Health Research (SMHR) Conference, Brisbane, Australia.

Whiteford, H. A. (18th November, 2015). Global burden of neuropsychiatric disorders. Presented at the 5th International Congress of Neurology and Epidemiology, Gold Coast, Australia.

Ferrari, A. J. (19th – 21st October, 2015). The burden attributable to substance use disorders as a risk factor for suicide. Presented (via pre-recording) to the WHO Meeting on Substance Use and Suicide in the International Context, Geneva, Switzerland.

Degenhardt, L. (9th October, 2015). Applications of epidemiological and burden of disease estimates for risk factor analysis: Injecting drug use as a risk factor in GBD 2013. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Charlson, F. J. (9th October, 2015). Applications of epidemiological and burden of disease estimates for targeted mental health planning. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Charlson, F. J. (9th October, 2015). Responding to a lack of data: the mental health survey in Lao PDR. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Erskine, H. E. (9th October, 2015). A known unknown: The global coverage of prevalence data for mental disorders in children and adolescents. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Ferrari, A. J. (9th October, 2015). Global burden of disease study 2013: An overview of methods, limitations and applications of data to estimate the burden of mental and substance use disorders. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Degenhardt, L. (9th October, 2015). Global burden of substance use disorders. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Whiteford, H. A. (9th October, 2015). Global burden of mental disorders. Presented at the 15th Congress of the International Federation of Psychiatric Epidemiology: Psychiatric epidemiology: the foundation for prevention and treatment planning, Bergen, Norway.

Ferrari, A. J., & Whiteford, H. A. (10th September, 2015). The burden attributable to mental and substance use disorders as risk factors for suicide. Presented at the World Suicide Prevention Day Forum, Brisbane, Australia.

Whiteford, H. A. (11th-14th May, 2015). Global burden of mental and substance use disorders. Presented at Creating Futures 2015: Practice, evidence and creativity in tropical and remote settings, Cairns, Australia.

Ferrari, A. J. (11th-14th May, 2015). Surveying the prevalence of mental and substance use disorders: Meeting standards for burden of disease analysis. Presented at Creating Futures 2015: Practice, evidence and creativity in tropical and remote settings, Cairns, Australia.

Charlson, F. J., & Erskine, H. E. (11th-14th May, 2015). Mental health if Indigenous people in Australia and the Pacific Islands: an epidemiological overview. Presented at Creating Futures 2015: Practice, evidence and creativity in tropical and remote settings, Cairns, Australia.

Whiteford, H. A. (27th-29th March, 2015). Updated estimates of burden due to mental and substance use disorders from the Global Burden of Disease Study 2015. Presented at the Twelfth Workshop on Costs and Assessment in Psychiatry – Mental Health Policy and Economics Research: Improving Access, Quality and Outcomes, International Centre of Mental Health Policy and Economics, Venice, Italy.

Erskine, H. E. (9 October, 2014). The global epidemiology and burden of conduct disorder and attention-deficit/hyperactivity disorder: Findings from the global burden of disease study 2010. Presented at the Faculty of Child and Adolescent Psychiatry 2014 Bi-national Conference, Gold Coast, Australia.

Scott, J. G., & Erskine, H. E. (9 October, 2014). “It is easier to build strong children than to repair broken men”: The global epidemiology and burden of mental disorders in children and youth. Presented at the Faculty of Child and Adolescent Psychiatry 2014 Bi-national Conference, Gold Coast, Australia.

Charlson, F. J., Moran, A. E., Norman, R. E., Baxter, A. J., Vos T., & Whiteford, H. A. (20-22nd October, 2013). The Contribution of Major Depression to the Global Burden of Ischemic Heart Disease: A systematic review and Comparative Risk Assessment. Presented at the Australasian Epidemiological Association Annual Scientific Meeting, Brisbane, Australia.

Erskine, H. E., Ferrari, A. J., Nelson, P., Polanczyk, G. V., Flaxman, A. D., Vos, T., Whiteford, H. A., & Scott, J. G. (18 October, 2013). Epidemiological modelling of childhood conduct disorder for the Global Burden of Disease Study 2010. Presented at the 4th Annual West Moreton Hospital and Health Services Research Day, Ipswich, Australia.

Ferrari, A.J., Charlson, F. J., Norman, R. E., Patten, S.B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (18 October, 2013). The Global Burden of Depressive Disorders: Findings from the Global Burden of Disease Study 2010. Presented at the 4th Annual West Moreton Hospital and Health Services Research Day, Ipswich, Australia.

Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Erskine, H. E., Ferrari, A. J., Charlson, F J., Norman, R. E., Flaxman, A. D., Johns, N., Burstein, R., Murray, C. J. L., & Vos, T. (18 October, 2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Presented at the 4th Annual West Moreton Hospital and Health Services Research Day, Ipswich, Australia.

Whiteford, H. A. (20-23 August, 2013). The Global Burden of Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study 2010. Presented at the 4th World Congress of Asian Psychiatry, Bangkok, Thailand.

Baxter, A. J., Erskine, H., Patton, G., Scott, K. M., Degenhardt, L., & Whiteford, H. A. (5-8 June, 2013). What’s missing in the epidemiology of mental disorders? Paper presented at the XIV International Congress of the International Federation of Psychiatric Epidemiology, Leipzig, Germany.

Erskine, H., Ferrari, A. J., Scott, J. G., Nelson, P., Vos, T., & Whiteford, H. (5-8 June, 2013). The global burden of conduct disorder: A case study in the Global Burden of Disease 2010 Study. Paper presented at the XIV International Congress of the International Federation of Psychiatric Epidemiology, Leipzig, Germany.

Degenhardt, L., Whiteford, H. A., Vos, T., Hall, W., Ferrari, A. J., Baxter, A., & Charlson, F. (5-8 June, 2013). The estimated burden of disease attributed to illicit drug use in GBD2010. Presented at the XIV International Congress of the International Federation of Psychiatric Epidemiology, Leipzig, Germany.

Whiteford, H. A., Degenhardt, L., Baxter, A. J., Ferrari, A. J., Erskine, H. E., & Charlson, F. (5-8 June, 2013). The global burden of mental disorders in 2010. Presented at the XIV International Congress of the International Federation of Psychiatric Epidemiology, Leipzig, Germany.

Degenhardt, L. (July 17-22, 2012). The Global Burden of Disease 2010 Study: An overview of findings for illicit drug use disorders. Oral presentation, WHO World Mental Health Survey Initiative Annual Collaborators’ Meeting. Brussels, Belgium.

Ferrari, A.J. (July 17-22, 2012). The Global Burden of Disease 2010 Study: Depressive disorders in the Global Burden of Disease 2010 Study: A case study. Oral presentation, WHO World Mental Health Survey Initiative Annual Collaborators’ Meeting. Brussels, Belgium.

Whiteford, H. A. (July 17-22, 2012). The Global Burden of Disease 2010 Study: An overview of findings for mental disorders. Oral presentation, WHO World Mental Health Survey Initiative Annual Collaborators’ Meeting. Brussels, Belgium.